|
1
|
Gray HJ, Bell-McGuinn K, Fleming GF,
Cristea M, Xiong H, Sullivan D, Luo Y, McKee MD, Munasinghe W and
Martin LP: Phase I combination study of the PARP inhibitor
veliparib plus carboplatin and gemcitabine in patients with
advanced ovarian cancer and other solid malignancies. Gynecol
Oncol. 148:507–514. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fu X, Zhang Y, Wang X, Chen M, Wang Y, Nie
J, Meng Y and Han W: Low dose decitabine combined with taxol and
platinum chemotherapy to treat refractory/recurrent ovarian cancer:
An open-label, single-arm, phase I/II study. Curr Protein Pept Sci.
16:329–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu GL, Yang HJ, Liu B and Liu T: Effects
of microRNA-19b on the proliferation, apoptosis, and migration of
Wilms' tumor cells via the PTEN/PI3K/AKT signaling pathway. J Cell
Biochem. 118:3424–3434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao J, Wu N, Liu X, Xia Y, Chen Y, Li S
and Deng Z: MicroRNA-142-3p inhibits cell proliferation and
chemoresistance in ovarian cancer via targeting sirtuin 1. Exp Ther
Med. 15:5205–5214. 2018.PubMed/NCBI
|
|
5
|
Liang H, Zhao X, Wang C, Sun J, Chen Y,
Wang G, Fang L, Yang R, Yu M, Gu Y and Shan H: Systematic analyses
reveal long non-coding RNA (PTAF)-mediated promotion of EMT and
invasion-metastasis in serous ovarian cancer. Mol Cancer.
17:962018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu DI, Liu L, Ren C, Kong D, Zhang P, Jin
X, Wang T and Zhang G: Epithelial-mesenchymal interconversions and
the regulatory function of the ZEB family during the development
and progression of ovarian cancer. Oncol Lett. 11:1463–1468. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sadlecki P, Jóźwicki J, Antosik P and
Grabiec M: Expression of selected epithelial-mesenchymal transition
transcription factors in serous borderline ovarian tumors and type
I ovarian cancers. Tumour Biol. 40:10104283187848072018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitra T, Prasad P, Mukherjee P, Chaudhuri
SR and Chatterji U: Stemness and chemoresistance are imparted to
the OC cells through TGFβ1 driven EMT. J Cell Biochem.
119:5775–5787. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leng R, Liao G, Wang H, Kuang J and Tang
L: Rac1 expression in epithelial ovarian cancer: Effect on cell EMT
and clinical outcome. Med Oncol. 32:3292015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weingarten C, Jenudi Y, Tshuva RY,
Moskovich D, Alfandari A, Hercbergs A, Davis PJ, Ellis M and
Ashur-Fabian O: The interplay between epithelial-mesenchymal
transition (EMT) and the thyroid hormones-αvβ3 axis in ovarian
cancer. Horm Cancer. 9:22–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng X, Huang F, Zhao A, Lei S, Zhang Y,
Xie G, Chen T, Qu C, Rajani C, Dong B, et al: Bile acid is a
significant host factor shaping the gut microbiome of diet-induced
obese mice. BMC Biol. 15:1202017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koshizuka K, Hanazawa T, Kikkawa N, Arai
T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y and Seki N:
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits
cancer cell migration and invasion in head and neck cancer. Cancer
Sci. 108:1681–1692. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blaha RZ, Arnett AB, Kirkwood MW, Taylor
HG, Stancin T, Brown TM and Wade SL: Factors influencing attrition
in a multisite, randomized, clinical trial following traumatic
brain injury in adolescence. J Head Trauma Rehabil. 30:E33–E40.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rochet N, Lindel K, Katayama S, Schubert
K, Herfarth K, Schneeweiss A, Sohn C, Harms W and Debus J:
Intensity-modulated whole abdomen irradiation following adjuvant
carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer:
Four-year outcomes. Strahlenther Onkol. 191:582–589. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim Y, Guntupalli SR, Lee SJ, Behbakht K,
Theodorescu D, Lee JK and Diamond JR: Retrospective analysis of
survival improvement by molecular biomarker-based personalized
chemotherapy for recurrent ovarian cancer. PLoS One. 9:e865322014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Záveský L, Jandáková E, Weinberger V,
Minář L, Hanzíková V, Dušková D, Drábková LZ, Svobodová I and
Hořínek A: Ascites-derived extracellular microRNAs as potential
biomarkers for ovarian cancer. Reprod Sci. 26:510–522. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loginov VI, Pronina IV, Burdennyy AM,
Filippova EA, Kazubskaya TP, Kushlinsky DN, Utkin DO, Khodyrev DS,
Kushlinskii NE, Dmitriev AA and Braga EA: Novel miRNA genes
deregulated by aberrant methylation in ovarian carcinoma are
involved in metastasis. Gene. 662:28–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bendoraite A, Knouf EC, Garg KS, Parkin
RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY,
Drescher CW, et al: Regulation of miR-200 family microRNAs and ZEB
transcription factors in ovarian cancer: Evidence supporting a
mesothelial-to-epithelial transition. Gynecol Oncol. 116:117–125.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu X, Wang Y, Qiu H, Song H, Feng D, Jiang
Y, Deng S, Meng H and Geng J: AEG-1 contributes to metastasis in
hypoxia-related ovarian cancer by modulating the
HIF-1alpha/NF-kappaB/VEGF pathway. Biomed Res Int.
2018:31456892018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu LJ, Duan Y, Wang P and Yin HQ:
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer
by down-regulating KLK10. Biochem Biophys Res Commun. 503:556–563.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao M, Zheng X, Jin B, Zhang F, Zhu L and
Cui L: Effects of CD44 and E-cadherin overexpression on the
proliferation, adhesion and invasion of ovarian cancer cells. Exp
Ther Med. 14:5557–5563. 2017.PubMed/NCBI
|
|
22
|
Wang YP, Wang QY, Li CH and Li XW: COX-2
inhibition by celecoxib in epithelial ovarian cancer attenuates
E-cadherin suppression through reduced Snail nuclear translocation.
Chem Biol Interact. 292:24–29. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang HN, Huang WC, Lin CH, Chiang YC,
Huang HY and Kuo KT: Chromosome 20q13.2 ZNF217 locus amplification
correlates with decreased E-cadherin expression in ovarian clear
cell carcinoma with PI3K-Akt pathway alterations. Hum Pathol.
45:2318–2325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Ma J, Shen H, Wang C, Sun Y,
Howell SB and Lin X: Reactive oxygen species promote ovarian cancer
progression via the HIF-1α/LOX/E-cadherin pathway. Oncol Rep.
32:2150–2158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Portune KJ, Benítez-Páez A, Del Pulgar EM,
Cerrudo V and Sanz Y: Gut microbiota, diet, and obesity-related
disorders-The good, the bad, and the future challenges. Mol Nutr
Food Res. 61:2017. View Article : Google Scholar : PubMed/NCBI
|
